Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> RearrangementsGabriele Varano, Reiner Siebert, Lorenzo Pignataro et al.|Blood Cancer Discovery|2025Cited by 5
Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung CancerJudith Mary Hariprakash, Francesco Ferrari, Elisa Salviato et al.|Cancer Research|2023Cited by 3
Data from Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung CancerJudith Mary Hariprakash, Francesco Ferrari, Elisa Salviato et al.|Unknown|2024Cited by 1
Supplementary Table S8 from Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung CancerJudith Mary Hariprakash, Francesco Ferrari, Elisa Salviato et al.|Unknown|2024Cited by 0